Company · CIK 1888886
Structure Therapeutics Inc.
| CIK | 1888886 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | CA |
| Listed | GPCR (Nasdaq) |
| First annual or quarterly report | 2023-03-30 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-289326 | 2025-08-06 | 2026-05-07 | 4 | |
| 333-279915 | 2024-06-03 | 2024-06-06 | 3 | |
| 333-275651 | 2023-11-17 | 2023-11-29 | 2 | |
| 333-269200 | 2023-01-12 | 2023-02-06 | 4 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-07 | 424B5Shelf takedown | 333-289326 | 0001104659-26-057160 |
| 2025-12-10 | 424B5Shelf takedown | 333-289326 | 0001104659-25-120013 |
| 2025-12-08 | 424B5Shelf takedown | 333-289326 | 0001104659-25-119370 |
| 2025-08-06 | S-3ASRShelf registered | 333-289326 | 0001104659-25-074777 |
| 2024-06-06 | 424B4Final prospectus | 333-279915 | 0001104659-24-069103 |
| 2024-06-05 | EFFECTDeclared effective | 333-279915 | 9999999995-24-001761 |
| 2024-06-03 | S-1Registration filed | 333-279915 | 0001104659-24-067768 |
| 2023-11-29 | EFFECTDeclared effective | 333-275651 | 9999999995-23-003494 |
| 2023-11-20 | DRSDraft made public | 377-06964 | 0001104659-23-119958 |
| 2023-11-17 | S-1Registration filed | 333-275651 | 0001104659-23-119620 |
| 2023-02-06 | 424B4Final prospectus | 333-269200 | 0001104659-23-010729 |
| 2023-02-02 | EFFECTDeclared effective | 333-269454 | 9999999995-23-000262 |
| 2023-02-02 | EFFECTDeclared effective | 333-269200 | 9999999995-23-000260 |
| 2023-01-30 | S-1/AAmendment | 333-269200 | 0001104659-23-007657 |
| 2023-01-12 | S-1Registration filed | 333-269200 | 0001104659-23-003415 |
| 2022-02-14 | DRSDraft made public | 377-06019 | 0001104659-22-021024 |